v3 Template
A

AIM ImmunoTech Inc.

Biotechnology/Healthcare OCALA, Fla. ~260 employees
Founded
--
Employees (Est.)
~260
13 leaders known
Total Funding
$31.3M
Funding Rounds
5
Last Funding
2026-01-23

About AIM ImmunoTech Inc.

AIM ImmunoTech is a biotechnology company focused on advancing therapeutic solutions through immunology for a better future. The company aims to develop innovative treatments to improve lives across various disease areas, including oncology, immune disorders, and viral diseases.

Products & Services

Ampligen(r):An immuno-modulator with broad spectrum activity shown in in-vitro and animal testing, currently being evaluated in clinical studies for a range of debilitating and life-threatening conditions.

Specialties

Immunology Immuno-Oncology Immune Disorders Viral Diseases

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Rights Offering
T: -
FT: Rights Offering
A: 12000000
MR: -
FA: 12 million
FAN: 12000000
D: 2026-01-23
FD: 2026-01-23
1 investors
2 RT: Public Offering
T: -
FT: Public Offering
A: 8000000
MR: -
FA: $8.0 Million
FAN: 8000000
D: 2025-07-31
FD: 2025-07-31
-
3 RT: Public Offering
T: -
FT: Public Offering
A: 8000000
MR: -
FA: 8.0 million
FAN: 8000000
D: 2025-07-29
FD: 2025-07-29
1 investors
4 RT: Registered Direct Offering and Private Placement
T: -
FT: Registered Direct Offering and Private Placement
A: 1260000
MR: -
FA: approximately $1.26 million
FAN: 1260000
D: 2024-09-30
FD: 2024-09-30
1 investors
5 RT: Registered Direct Offering
T: -
FT: Registered Direct Offering
A: 2000000
MR: -
FA: $2.0 million
FAN: 2000000
D: 2024-05-31
FD: 2024-05-31
1 investors
Rights Offering Latest
2026-01-23
$12.0M
1 investor (Pro only)
Public Offering 2025-07-31
$8.0M
Public Offering 2025-07-29
$8.0M

View 4 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

T

Thomas K Equels

Chief Executive Officer, President & Executive Vice Chairman

J

Jenene Thomas

Investor Relations Contact

W

W. Neal Burnette

Chairman

W

William M. Mitchell

Chairman of the Board

R

Ronald Brus

Physician

C

Christopher Nicodemus

Consulting Science Officer

View 10 more team members with Pro

Unlock Full Team Directory

Recent News

AIM ImmunoTech Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biotechnology/Healthcare
Company Size
~260 employees (est.)
Locations
OCALA, Fla.
Ocala, Florida, USA
Ocala, Fla., USA +2 more

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro